Other Lipid Metabolism
Inhibitors |
Cat. No. | Product Name / Activity |
|---|---|
| 5762 | BMS 795311 |
| Potent cholesteryl ester transfer protein (CETP) inhibitor | |
| 6319 | CBM 301940 |
| Potent malonyl-CoA decarboxylase inhibitor; orally bioavailable | |
| 6765 | JTP 103237 |
| Potent and selective monoacyglycerol acyltransferase 2 (MOGAT2) inhibitor | |
| 5631 | LDN 193188 |
| Inhibitor of phosphatidylcholine transfer protein (PC-TP) | |
| 5790 | PF 05175157 |
| Acetyl-CoA carboxylase (ACC) 1 and 2 inhibitor | |
| 1842 | RHC 80267 |
| Diacylglycerol lipase inhibitor | |
| 5389 | Ro 48-8071 fumarate |
| 2,3-Oxidosqualene cyclase (OSC) inhibitor; blocks cholesterol synthesis | |
| 4189 | SC 26196 |
| Selective FADS2 inhibitor | |
| 6106 | T 3364366 |
| Potent and reversible FADS1 inhibitor; orally bioavailable | |
| 4184 | Torcetrapib |
| Inhibitor of cholesteryl ester transfer protein (CETP) | |
| 5259 | WWL 113 |
| Ces3 and Ces1f inhibitor | |
Other |
Cat. No. | Product Name / Activity |
| 0355 | (±)-Acetylcarnitine chloride |
| Intermediate in lipid metabolism | |
| 2784 | Acipimox |
| Antilipolytic agent | |
| 0477 | (±)-Decanoylcarnitine chloride |
| Intermediate in lipid metabolism | |
| 0526 | (±)-Hexanoylcarnitine chloride |
| Intermediate in lipid metabolism | |
| 0548 | (±)-Lauroylcarnitine chloride |
| Intermediate in lipid metabolism | |
| 0567 | (±)-Myristoylcarnitine chloride |
| Intermediate in lipid metabolism | |
| 0605 | (±)-Octanoylcarnitine chloride |
| Intermediate in lipid metabolism | |
| 0878 | Oleamide |
| Sleep-inducing brain lipid | |
| 1484 | Oleylethanolamide |
| Lipid mediator, anorexic actions; also GPR55 and PPARα agonist | |
| 0609 | (±)-Palmitoylcarnitine chloride |
| Intermediate in fatty acid oxidation | |
| 0611 | (±)-Propionylcarnitine chloride |
| Intermediate in lipid metabolism | |